Cargando…
Improved immunogenicity against SARS-CoV-2 in a solid-organ transplant recipient by switching vaccines
Autores principales: | al Jalali, Valentin, Scherzer, Sabine, Zeitlinger, Markus |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
European Society of Clinical Microbiology and Infectious Diseases. Published by Elsevier Ltd.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8236129/ https://www.ncbi.nlm.nih.gov/pubmed/34192576 http://dx.doi.org/10.1016/j.cmi.2021.06.022 |
Ejemplares similares
-
Immunogenicity of SARS‐CoV‐2 mRNA vaccine in solid organ transplant recipients
por: Holden, Inge K., et al.
Publicado: (2021) -
SARS-CoV-2 Vaccines: Safety and Immunogenicity in Solid Organ Transplant Recipients and Strategies for Improving Vaccine Responses
por: Grupper, Ayelet, et al.
Publicado: (2022) -
Immune Responses to SARS-CoV-2 in Solid Organ Transplant Recipients
por: Phadke, Varun K., et al.
Publicado: (2021) -
Antibody Kinetics and Durability in SARS-CoV-2 mRNA Vaccinated Solid Organ Transplant Recipients
por: Boyarsky, Brian J., et al.
Publicado: (2021) -
Is the outcome of SARS-CoV-2 infection in solid organ transplant recipients really similar to that of the general population?
por: Mendoza, Maria A., et al.
Publicado: (2021)